chr19:40736224:> Detail (hg19) (AKT2)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr19:40,736,224-40,791,302 |
| hg38 | chr19:40,230,317-40,285,395 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
| Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
|---|---|---|---|---|---|---|---|---|---|
| breast cancer | Trastuzumab | B |
Predictive
|
Supports
|
Sensitivity/Response | Somatic | 3 | 22842582 | Detail |
DisGeNET
[No Data.]
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| In HER2+ metastatic breast cancer treated with trastuzumab (n = 74 patients), the expression of AKT2... | CIViC Evidence | Detail |
| Metabotropic glutamate receptor 1 (Grm1) acts as an oncogene in vitro and in vivo. A reduction in tu... | MMMP | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- Genome
- hg19
- Position
- chr19:40,736,224-40,791,302
- Variant Type
- snv
- Variant (CIViC) (CIViC Variant)
- EXPRESSION
- Transcript 1 (CIViC Variant)
- ENST00000392038.2
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/278
Genome browser